Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 6
Mundipharma International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Mundipharma International Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
Mundipharma International Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Mundipharma International Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
Mundipharma International Ltd, Medical Devices Deals, 2012 to YTD 2018 11
Mundipharma International Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Mundipharma International Ltd, Pharmaceuticals & Healthcare, Deal Details 15
Asset Purchase 15
Mundipharma Acquires Rights to CAP7.1 from CellAct 15
Mundipharma Ophthalmology Acquires Glaucoma Products Portfolio from Merck 16
Purdue Pharma Acquires Rights to VM-902A from VM Pharma 17
Venture Financing 18
Kolltan Pharma Raises US$60 Million In Series D Financing 18
Partnerships 20
Mundipharma Medical and Purdue Pharma Enter into Licensing Agreement with Esteve 20
Mundipharma Expands Agreement with Kolon Life Science 21
University of Texas Health Science Center Enters into Co-Development Agreement with Purdue Pharma 22
University of Nebraska Medical Center and Purdue Pharma Enter into Agreement 23
Mundipharma Enters into Distribution Agreement with Shionogi 24
Purdue Pharma to Form Joint Venture with AnaBios 25
Eisai Enters into Agreement with Purdue Pharma 26
Mundipharma and Purdue Pharma Enter into Development Agreement with Esteve 27
Horizon Pharma And Mundipharma Amend Distribution Agreement For Lodotra 28
ElMindA Enters Into Agreement With Purdue Pharma To Develop New Pain Drugs 30
Mundipharma International Enters Into Co-Development Agreement With Northlake International For NL-101 31
Horizon Pharma Amends Co-Marketing Agreement With Mundipharma International For LODOTRA 33
Licensing Agreements 35
Mundipharma Enters into Licensing Agreement with Neovii Pharma 35
Mundipharma Enters into Licensing Agreement with Starpharma Holding 36
Mundipharma Enters into Licensing Agreement with Grunenthal 37
Mundipharma Enters into Licensing Agreement with Paion 38
Mundipharma Enters into Licensing Agreement with APR Applied Pharma Research 39
Purdue Pharma Canada Enters into Licensing Agreement with Klaria Pharma 40
Purdue Pharma (Canada) Enters into Licensing Agreement with BioDelivery Sciences International 41
Purdue Pharma Canada Enters into Licensing Agreement with Helsinn Group 42
Mundipharma Enters into Licensing Agreement with Vectura for VR2076 43
Purdue Pharma Enters into Licensing Agreement with Exicure 44
Purdue Pharma Enters into Licensing agreement with AnaBios 45
Purdue Pharma Enters Into Licensing Agreement With Medical Developments 46
Mundipharma International Enters into Licensing Agreement with Orexo 47
Helsinn Signs Licensing Agreement with Purdue Pharma Canada 48
Mundipharma Enters into Licensing Agreement with Specialized Therapeutics 49
Mundipharma International Enters into Licensing Agreement with Helsinn 50
Mundipharma Enters into Licensing Agreement with SkyePharma and Sanofi for Flutiform 51
SkyePharma Enters into Option Agreement with Mundipharma 52
Mundipharma Enters into Licensing Agreement with Spectrum Pharma for Zevalin 53
Mundipharma Enters into Licensing Agreement with Medical Developments for Penthrox 55
Mundipharma Enters into Licensing Agreement with Helsinn 56
Helsinn Enters into Licensing Agreement with Mundipharma for Anamorelin 57
Helsinn Enters into Licensing Agreement with Mundipharma for NEPA 58
Mundipharma Enters into Licensing Agreement with Celltrion Healthcare Hungary for Remsima 59
Mundipharma Enters into Licensing Agreement with Genewel for Medifoam 61
Mundipharma Enters Into Licensing Agreement With Grunenthal 62
Helsinn Enters Into Licensing Agreement With Mundipharma For Netupitant-Palonosetron Fixed Dose Combination 63
Mundipharma Plans to Extend Licensing Agreement with Genewel for Medifoam 64
Mundipharma Enters Into Licensing Agreement With Shionogi 65
Grunenthal Enters Into Licensing Agreement With Purdue Pharma For IP Rights To Abuse-Deterrent Formulation Technology 66
Actavis Enters Into Licensing Agreement With Purdue Pharma For Generic OxyContin 67
Asset Transactions 68
Fidelio Healthcare Partners to Acquire Production Site and Facilities from Mundipharma 68
Acquisition 69
Mundipharma Acquires Tolmar Australia 69
Mundipharma International Ltd – Key Competitors 70
Mundipharma International Ltd – Key Employees 71
Mundipharma International Ltd – Locations And Subsidiaries 72
Head Office 72
Other Locations & Subsidiaries 72
Joint Venture 75
Recent Developments 76
Corporate Communications 76
Dec 13, 2017: Dr Alberto Martinez appointed President and CEO of Mundipharma International 76
Dec 05, 2017: Mundipharma appoints Chief Information Officer 77
Appendix 78
Methodology 78
About GlobalData 78
Contact Us 78
Disclaimer 78
Mundipharma International Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Mundipharma International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Mundipharma International Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
Mundipharma International Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Mundipharma International Ltd, Deals By Therapy Area, 2012 to YTD 2018 10
Mundipharma International Ltd, Medical Devices Deals, 2012 to YTD 2018 11
Mundipharma International Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Mundipharma Acquires Rights to CAP7.1 from CellAct 15
Mundipharma Ophthalmology Acquires Glaucoma Products Portfolio from Merck 16
Purdue Pharma Acquires Rights to VM-902A from VM Pharma 17
Kolltan Pharma Raises US$60 Million In Series D Financing 18
Mundipharma Medical and Purdue Pharma Enter into Licensing Agreement with Esteve 20
Mundipharma Expands Agreement with Kolon Life Science 21
University of Texas Health Science Center Enters into Co-Development Agreement with Purdue Pharma 22
University of Nebraska Medical Center and Purdue Pharma Enter into Agreement 23
Mundipharma Enters into Distribution Agreement with Shionogi 24
Purdue Pharma to Form Joint Venture with AnaBios 25
Eisai Enters into Agreement with Purdue Pharma 26
Mundipharma and Purdue Pharma Enter into Development Agreement with Esteve 27
Horizon Pharma And Mundipharma Amend Distribution Agreement For Lodotra 28
ElMindA Enters Into Agreement With Purdue Pharma To Develop New Pain Drugs 30
Mundipharma International Enters Into Co-Development Agreement With Northlake International For NL-101 31
Horizon Pharma Amends Co-Marketing Agreement With Mundipharma International For LODOTRA 33
Mundipharma Enters into Licensing Agreement with Neovii Pharma 35
Mundipharma Enters into Licensing Agreement with Starpharma Holding 36
Mundipharma Enters into Licensing Agreement with Grunenthal 37
Mundipharma Enters into Licensing Agreement with Paion 38
Mundipharma Enters into Licensing Agreement with APR Applied Pharma Research 39
Purdue Pharma Canada Enters into Licensing Agreement with Klaria Pharma 40
Purdue Pharma (Canada) Enters into Licensing Agreement with BioDelivery Sciences International 41
Purdue Pharma Canada Enters into Licensing Agreement with Helsinn Group 42
Mundipharma Enters into Licensing Agreement with Vectura for VR2076 43
Purdue Pharma Enters into Licensing Agreement with Exicure 44
Purdue Pharma Enters into Licensing agreement with AnaBios 45
Purdue Pharma Enters Into Licensing Agreement With Medical Developments 46
Mundipharma International Enters into Licensing Agreement with Orexo 47
Helsinn Signs Licensing Agreement with Purdue Pharma Canada 48
Mundipharma Enters into Licensing Agreement with Specialized Therapeutics 49
Mundipharma International Enters into Licensing Agreement with Helsinn 50
Mundipharma Enters into Licensing Agreement with SkyePharma and Sanofi for Flutiform 51
SkyePharma Enters into Option Agreement with Mundipharma 52
Mundipharma Enters into Licensing Agreement with Spectrum Pharma for Zevalin 53
Mundipharma Enters into Licensing Agreement with Medical Developments for Penthrox 55
Mundipharma Enters into Licensing Agreement with Helsinn 56
Helsinn Enters into Licensing Agreement with Mundipharma for Anamorelin 57
Helsinn Enters into Licensing Agreement with Mundipharma for NEPA 58
Mundipharma Enters into Licensing Agreement with Celltrion Healthcare Hungary for Remsima 59
Mundipharma Enters into Licensing Agreement with Genewel for Medifoam 61
Mundipharma Enters Into Licensing Agreement With Grunenthal 62
Helsinn Enters Into Licensing Agreement With Mundipharma For Netupitant-Palonosetron Fixed Dose Combination 63
Mundipharma Plans to Extend Licensing Agreement with Genewel for Medifoam 64
Mundipharma Enters Into Licensing Agreement With Shionogi 65
Grunenthal Enters Into Licensing Agreement With Purdue Pharma For IP Rights To Abuse-Deterrent Formulation Technology 66
Actavis Enters Into Licensing Agreement With Purdue Pharma For Generic OxyContin 67
Fidelio Healthcare Partners to Acquire Production Site and Facilities from Mundipharma 68
Mundipharma Acquires Tolmar Australia 69
Mundipharma International Ltd, Key Competitors 70
Mundipharma International Ltd, Key Employees 71
Mundipharma International Ltd, Subsidiaries 72
Mundipharma International Ltd, Joint Venture 75
List of Figures
Mundipharma International Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Mundipharma International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Mundipharma International Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Mundipharma International Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Mundipharma International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Mundipharma International Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 8
Mundipharma International Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Mundipharma International Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
Mundipharma International Ltd, Medical Devices Deals, 2012 to YTD 2018 11